Side-by-side comparison
Larazotide Acetate vs Capromorelin
Tight-junction regulator developed for celiac disease; reduces intestinal permeability. versus Oral non-peptide ghrelin-receptor agonist; FDA-approved as a veterinary appetite stimulant.
Larazotide Acetate
RecoveryTight-junction regulator developed for celiac disease; reduces intestinal permeability.
Top benefits
- ✓Tightens intestinal junctions
- ✓Reduces leaky-gut markers
- ✓Studied in celiac disease
Capromorelin
PerformanceOral non-peptide ghrelin-receptor agonist; FDA-approved as a veterinary appetite stimulant.
Top benefits
- ✓Stimulates appetite
- ✓Raises GH/IGF-1
- ✓Oral bioavailability
| Attribute | Larazotide Acetate | Capromorelin |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | small-molecule |
| Chain length | 8 aa | 1 aa |
| Formula | C39H56N10O15 | C28H36N4O4 |
| Common dose | 0.5 mg | 3 mg/kg (dog) |
| Frequency | 3x daily, oral | Daily, oral |
| Top benefit | Tightens intestinal junctions | Stimulates appetite |
| Top side-effect | Headache | Hypersalivation (in dogs/cats) |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.